Citations (34)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Angelina F. Gomez, Abigail L. Barthel & Stefan G. Hofmann. (2018) Comparing the efficacy of benzodiazepines and serotonergic anti-depressants for adults with generalized anxiety disorder: a meta-analytic review. Expert Opinion on Pharmacotherapy 19:8, pages 883-894.
Read now
Read now
H. Parmentier, J. García-Campayo & R. Prieto. (2013) Comprehensive review of generalized anxiety disorder in primary care in Europe. Current Medical Research and Opinion 29:4, pages 355-367.
Read now
Read now
Trevor R Norman & James S Olver. (2008) Duloxetine in the treatment of generalized anxiety disorder. Neuropsychiatric Disease and Treatment 4:6, pages 1169-1180.
Read now
Read now
Domenico De Berardis, Nicola Serroni, Alessandro Carano, Marco Scali, Alessandro Valchera, Daniela Campanella, Alessandro D’Albenzio, Berardo Di Giuseppe, Francesco Saverio Moschetta, Rosa Maria Salerno & Filippo Maria Ferro. (2008) The role of duloxetine in the treatment of anxiety disorders. Neuropsychiatric Disease and Treatment 4:5, pages 929-935.
Read now
Read now
Articles from other publishers (30)
Takashi Hirase, Jessica Hirase, Jeremiah Ling, Peggy H Kuo, Gilbert A Hernandez, Kayode Giwa & Rex Marco. (2021) Duloxetine for the Treatment of Chronic Low Back Pain: A Systematic Review of Randomized Placebo-Controlled Trials. Cureus.
Crossref
Crossref
Marianna de Abreu Costa, Francine Guimarães Gonçalves, Tiago Tatton-Ramos, Natasha Kim de Oliveira da Fonseca, Julia Karl Schwinn, Sofia Giusti Alves, Giovanni Abrahão Salum & Gisele Gus Manfro. (2021) A Three-Arm Randomized Clinical Trial Comparing the Efficacy of a Mindfulness-Based Intervention with an Active Comparison Group and Fluoxetine Treatment for Adults with Generalized Anxiety Disorder. Psychotherapy and Psychosomatics 90:4, pages 269-279.
Crossref
Crossref
Gavin Andrews, Caroline Bell, Philip Boyce, Christopher Gale, Lisa Lampe, Omar Marwat, Ronald Rapee & Gregory Wilkins. (2018) Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of panic disorder, social anxiety disorder and generalised anxiety disorder. Australian & New Zealand Journal of Psychiatry 52:12, pages 1109-1172.
Crossref
Crossref
Katharina Domschke, Hans-Peter Kapfhammer & Jürgen Deckert. 2017. Psychiatrie, Psychosomatik, Psychotherapie. Psychiatrie, Psychosomatik, Psychotherapie
1857
1932
.
Yingli Zhang, Guoping Huang, Shichang Yang, Wei Liang, Lei Zhang & Changhong Wang. (2016) Duloxetine in treating generalized anxiety disorder in adults: A meta-analysis of published randomized, double-blind, placebo-controlled trials. Asia-Pacific Psychiatry 8:3, pages 215-225.
Crossref
Crossref
Regina P. SchukroMatthias J. OehmkeAngelika GeroldingerGeorg HeinzeHans-Georg KressSibylle Pramhas. (2016) Efficacy of Duloxetine in Chronic Low Back Pain with a Neuropathic Component. Anesthesiology 124:1, pages 150-158.
Crossref
Crossref
Katharina Domschke, Hans-Peter Kapfhammer & Jürgen Deckert. 2016. Psychiatrie, Psychosomatik, Psychotherapie. Psychiatrie, Psychosomatik, Psychotherapie
1
77
.
Bret R Rutherford, Veronika S. Bailey, Franklin R. Schneier, Emily Pott, Patrick J. Brown & Steven P. Roose. (2015) INFLUENCE OF STUDY DESIGN ON TREATMENT RESPONSE IN ANXIETY DISORDER CLINICAL TRIALS. Depression and Anxiety 32:12, pages 944-957.
Crossref
Crossref
Chi-Un Pae, Sheng-Min Wang, Changsu Han, Soo-Jung Lee, Ashwin A. Patkar, Praksh S. Masand & Alessandro Serretti. (2015) Vortioxetine, a multimodal antidepressant for generalized anxiety disorder: A systematic review and meta-analysis. Journal of Psychiatric Research 64, pages 88-98.
Crossref
Crossref
Siegfried Kasper, Markus Gastpar, Walter E M?ller, Hans-Peter Volz, Hans-J?rgen M?ller, Sandra Schl?fke & Angelika Dienel. (2014) Lavender oil preparation Silexan is effective in generalized anxiety disorder ? a randomized, double-blind comparison to placebo and paroxetine. The International Journal of Neuropsychopharmacology 17:06, pages 859-869.
Crossref
Crossref
Françoise Couic-Marinier, Florine Harnist & Annelise Lobstein. (2014) En savoir plus sur l’huile essentielle de Lavande officinale. Actualités Pharmaceutiques 53:535, pages 37-40.
Crossref
Crossref
Belén Arranz. (2014) Duloxetina y trastorno de ansiedad generalizada, una buena asociación. Psiquiatría Biológica 21:1, pages 3-8.
Crossref
Crossref
Dennis A. Revicki, Karin Travers, Kathleen W. Wyrwich, Henrik Svedsäter, Julie Locklear, Maria Stoeckl Mattera, David V. Sheehan & Stuart Montgomery. (2012) Humanistic and economic burden of generalized anxiety disorder in North America and Europe. Journal of Affective Disorders 140:2, pages 103-112.
Crossref
Crossref
Mary Pat Knadler, Evelyn Lobo, Jill Chappell & Richard Bergstrom. (2011) Duloxetine. Clinical Pharmacokinetics 50:5, pages 281-294.
Crossref
Crossref
Martin A. Katzman, Alex Copeland, Larry J. Klassen, Pratap Chokka & Olga Brawman-Mintzer. (2011) Pharmacotherapy for Generalized Anxiety Disorder. Psychiatric Annals 41:2, pages 95-103.
Crossref
Crossref
SD Hood, JK Melichar, LG Taylor, N Kalk, TR Edwards, DA Hince, A Lenox-Smith, AR Lingford-Hughes & DJ Nutt. (2010) Noradrenergic function in generalized anxiety disorder: impact of treatment with venlafaxine on the physiological and psychological responses to clonidine challenge. Journal of Psychopharmacology 25:1, pages 78-86.
Crossref
Crossref
H.-P. Kapfhammer. 2011. Psychiatrie, Psychosomatik, Psychotherapie. Psychiatrie, Psychosomatik, Psychotherapie
1702
1773
.
Siegfried Kasper, Markus Gastpar, Walter E. Müller, Hans-Peter Volz, Hans-Jürgen Möller, Angelika Dienel & Sandra Schläfke. (2010) Silexan, an orally administered Lavandula oil preparation, is effective in the treatment of ‘subsyndromal’ anxiety disorder: a randomized, double-blind, placebo controlled trial. International Clinical Psychopharmacology 25:5, pages 277-287.
Crossref
Crossref
Evelyn D. Lobo, Michael Heathman, Han-Yi Kuan, Shobha Reddy, Lisa OʼBrien, Celedon Gonzales, Michael Skinner & Mary Pat Knadler. (2010) Effects of Varying Degrees of Renal Impairment on the Pharmacokinetics of Duloxetine. Clinical Pharmacokinetics 49:5, pages 311-321.
Crossref
Crossref
S. Bellino, E. Paradiso, P. Bozzatello & F. Bogetto. (2008) Efficacy and tolerability of duloxetine in the treatment of patients with borderline personality disorder: a pilot study. Journal of Psychopharmacology 24:3, pages 333-339.
Crossref
Crossref
Bernardo Dell'Osso, Massimiliano Buoli, David S. Baldwin & A. Carlo Altamura. (2009) Serotonin norepinephrine reuptake inhibitors (SNRIs) in anxiety disorders: a comprehensive review of their clinical efficacy. Human Psychopharmacology: Clinical and Experimental 25:1, pages 17-29.
Crossref
Crossref
Jill Chappell, Jingsong He, Mary Pat Knadler, Malcolm Mitchell, Douglas Lee & Evelyn Lobo. (2013) Effects of Duloxetine on the Pharmacodynamics and Pharmacokinetics of Warfarin at Steady State in Healthy Subjects. The Journal of Clinical Pharmacology 49:12, pages 1456-1466.
Crossref
Crossref
Chi-Un Pae, David M. Marks, Manan Shah, Changsu Han, Byung-Joo Ham, Ashwin A. Patkar & Prakash S. Masand. (2009) Milnacipran. Clinical Neuropharmacology 32:6, pages 355-363.
Crossref
Crossref
V. Skljarevski, M. Ossanna, H. Liu-Seifert, Q. Zhang, A. Chappell, S. Iyengar, M. Detke & M. Backonja. (2009) A double-blind, randomized trial of duloxetine versus placebo in the management of chronic low back pain. European Journal of Neurology 16:9, pages 1041-1048.
Crossref
Crossref
Katja Beesdo, Jürgen Hoyer, Frank Jacobi, Nancy C.P. Low, Michael Höfler & Hans-Ulrich Wittchen. (2009) Association between generalized anxiety levels and pain in a community sample: Evidence for diagnostic specificity. Journal of Anxiety Disorders 23:5, pages 684-693.
Crossref
Crossref
H. Nicolini, D. Bakish, H. Duenas, M. Spann, J. Erickson, C. Hallberg, S. Ball, D. Sagman & J. M. Russell. (2008) Improvement of psychic and somatic symptoms in adult patients with generalized anxiety disorder: examination from a duloxetine, venlafaxine extended-release and placebo-controlled trial. Psychological Medicine 39:2, pages 267-276.
Crossref
Crossref
Martin A. Katzman. (2009) Current Considerations in the Treatment of Generalized Anxiety Disorder. CNS Drugs 23:2, pages 103-120.
Crossref
Crossref
Basil G Bereza, Márcio Machado & Thomas R Einarson. (2008) Assessing the Reporting and Scientific Quality of Meta-Analyses of Randomized Controlled Trials of Treatments for Anxiety Disorders. Annals of Pharmacotherapy 42:10, pages 1402-1409.
Crossref
Crossref
Jonathan R.T. Davidson, Hans-Ulrich Wittchen, Pierre-Michel Llorca, Janelle Erickson, Michael Detke, Susan G. Ball & James M. Russell. (2008) Duloxetine treatment for relapse prevention in adults with generalized anxiety disorder: A double-blind placebo-controlled trial. European Neuropsychopharmacology 18:9, pages 673-681.
Crossref
Crossref
C Allgulander, D Nutt, M Detke, J Erickson, M Spann, D Walker, SG Ball & JM Russell. (2008) A non-inferiority comparison of duloxetine and venlafaxine in the treatment of adult patients with generalized anxiety disorder. Journal of Psychopharmacology 22:4, pages 417-425.
Crossref
Crossref